title: Sitagliptin-associated drug allergy: review of spontaneous adverse event reports.
authors.forename: Shrey
authors.initials: S
authors.lastname: Desai
authors.forename: Allen
authors.initials: A
authors.lastname: Brinker
authors.forename: Joslyn
authors.initials: J
authors.lastname: Swann
authors.forename: Solomon
authors.initials: S
authors.lastname: Iyasu
mesh_terms: D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000368:Aged; D000369:Aged, 80 and over; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000453:epidemiology*; D005260:Female; D052216:Glucagon-Like Peptide 1; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000009:adverse effects* / Q000627:therapeutic use; D012189:Retrospective Studies; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D011719:Pyrazines; D014230:Triazoles; D052216:Glucagon-Like Peptide 1; D000068900:Sitagliptin Phosphate